Ayush Min, CSIR pact to boost Indian herbal drug industry

Image
Press Trust of India New Delhi
Last Updated : May 03 2019 | 2:40 PM IST

The Ayush Ministry and the country's premier research agency, the Council of Scientific and Industrial Research (CSIR), have joined hands to explore modern scientific methods for integration with traditional medicine to boost prospects of Indian herbal products in the global market.

According to the MoU between the two organisations, emphasis will be on research and development, ayush-specific diagnostic tools, multi-ingredient herbal formulations and their standardisation among others, said a ministry official.

Various CSIR labs have already taken initiatives in this direction in the past too, for instance, scientists from the Central Institute of Medicinal and Aromatic Plants (CIMAP) and the National Botanical Research Institute (NBRI), had jointly developed anti-diabetic herbal drug BGR-34 a few years ago, another official said.

The scientifically validated poly-herbal ayurvedic blood glucose regulator BGR-34 has been prepared from six medicinal plants including Daruharidra, Giloy, Gudmar and bitter gourds which are known for their anti-diabetic and anti-hyperglycemic properties. It is being marketed by Delhi-based AIMIL Pharmaceuticals.

The MoU was signed recently by Vaidya Rajesh Kotecha, Union Ayush Secretary and Dr Shekhar C Mande, Director General, CSIR.

As per the pact, the collaboration in preserving and protecting traditional knowledge related to the Indian systems of healthcare will also be strengthened through existing platforms and development of international standardized terminologies (disease-morbidity codes) in Ayurveda, Siddha and Unani (ASU), database on medicinal plants, foods, etc.

Talking about importance of such handholdings, Kotecha said in view of the growing interest in traditional medicines worldwide, there is a need for multi-pronged and innovative approaches for acceptance of this science.

The combination of traditional healthcare and modern basic science has a huge possibility for innovative and path-breaking researches which can be used for the explanation of various basic concepts.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 03 2019 | 2:40 PM IST

Next Story